Metropolis Healthcare Ltd Q4 consolidated PAT drops to Rs. 15.49 crore

Metropolis Healthcare Ltd has reported financial results for the period ended March 31, 2020.

Financial Results (Q4 FY19-20) - QoQ Comparison

The company has reported total income of Rs.210.04 crores during the period ended March 31, 2020 as compared to Rs.202.57 crores during the period ended December 31, 2019.

The company has posted net profit / (loss) of Rs.15.49 crores for the period ended March 31, 2020 as against net profit / (loss) of Rs.34.48 crores for the period ended December 31, 2019.

The company has reported EPS of Rs.3.07 for the period ended March 31, 2020 as compared to Rs.6.86 for the period ended December 31, 2019.

Financials	Q4 FY19-20	Q3 FY19-20	% Change
Total Income	₹ 210.04 crs	₹ 202.57 crs	3.69%
Net Profit	₹ 15.49 crs	₹ 34.48 crs	-55.08%
EPS	₹ 3.07	₹ 6.86	-55.25%

Financial Results (Q4 FY19-20) - YoY Comparison

The company has reported total income of Rs.210.04 crores during the period ended March 31, 2020 as compared to Rs.225.04 crores during the period ended March 31, 2019.

The company has posted net profit / (loss) of Rs.15.49 crores for the period ended March 31, 2020 as against net profit / (loss) of Rs.42.07 crores for the period ended March 31, 2019.

The company has reported EPS of Rs.3.07 for the period ended March 31, 2020 as compared to Rs.8.37 for the period ended March 31, 2019.

Financials	Q4 FY19-20	Q4 FY18-19	% Change
Total Income	₹ 210.04 crs	₹ 225.04 crs	-6.67%
Net Profit	₹ 15.49 crs	₹ 42.07 crs	-63.18%
EPS	₹ 3.07	₹ 8.37	-63.32%

Financial Results (12 months ended FY 19-20) - YoY Comparison

The company has reported total income of Rs.864.97 crores during the 12 months period ended March 31, 2020 as compared to Rs.769.39 crores during the 12 months period ended March 31, 2019.

The company has posted net profit / (loss) of Rs.127.32 crores for the 12 months period ended March 31, 2020 as against net profit / (loss) of Rs.120.14 crores for the 12 months period ended March 31, 2019.

The company has reported EPS of Rs.25.25 for the 12 months period ended March 31, 2020 as compared to Rs.24.02 for the 12 months period ended March 31, 2019.

Financials	Year Ended FY19-20	Year Ended FY18-19	% Change
Total Income	₹ 864.97 crs	₹ 769.39 crs	12.42%
Net Profit	₹ 127.32 crs	₹ 120.14 crs	5.98%
EPS	₹ 25.25	₹24.02	5.12%

"We are at frontlines of COVID 19 testing and our team is working with a deep sense of urgency and commitment to make sure that patients and doctors get reliable diagnosis as early as possible. The Pandemic has put the diagnostic industry at the cusp of a dynamic shift and established pathology chains like us are set to benefit and cement leadership position. Additionally, as business returns to normal, the momentum will shift in favour of COVID capable labs with customers increasingly choosing trusted brands that offer quality, safety, and reliability. Increased engagement with government and regulatory authorities has opened new avenues and possibilities in the future.

Digital transformation, a growing test menu, and a relentless pursuit of superior customer experience has made Metropolis stronger in our core markets even as we acquire market share in other geographies. We will continue to put quality, safety, and hygiene at the core of patient service." Ameera Shah, Promoter and Managing Director, Metropolis Healthcare Ltd.

Shares of Metropolis Healthcare Ltd. was last trading in BSE at Rs.26 as compared to the previous close of Rs. 26.15. The total number of shares traded during the day was 1361 in over 58 trades.

The stock hit an intraday high of Rs. 26.55 and intraday low of 25.6. The net turnover during the day was Rs. 35556.

Source : Equity Bulls

Keywords